Related Experiment Videos

Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex

J P Medema1, C Scaffidi, P H Krammer

  • 1Tumor Immunology Program, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

Insights

Bcl-xL overexpression confers resistance to CD95-mediated apoptosis by acting downstream of caspase-8 activation. This anti-apoptotic protein does not prevent caspase-8 recruitment or activity at the DISC, but inhibits downstream signaling.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Bcl-xL, a Bcl-2 family member, is linked to apoptosis resistance.
  • Previous findings showed increased Bcl-xL expression in T cells resistant to CD95-mediated apoptosis.
  • This suggested Bcl-xL might inhibit caspase-8 activation at the DISC.

Purpose of the Study:

  • To investigate if Bcl-xL directly inhibits caspase-8 activation by the DISC.
  • To determine the mechanism by which Bcl-xL confers resistance to CD95-induced apoptosis.

Main Methods:

  • Utilized MCF7-Fas-bcl-xL cells overexpressing Bcl-xL to study CD95 signaling.
  • Assessed caspase-8 recruitment to the DISC and its enzymatic activity.
  • Performed immunoprecipitation assays to detect interactions between Bcl-xL and caspase-8.
  • Monitored cleavage of caspase-3 substrates like poly(ADP-ribose) polymerase.

Main Results:

  • Bcl-xL overexpression did not affect caspase-8 recruitment to the DISC or its activation.
  • Cleavage of caspase-3 substrates was inhibited in Bcl-xL overexpressing cells.
  • No physical interaction was detected between Bcl-xL and caspase-8.
  • Bcl-xL did not inhibit the activity of active caspase-8 subunits.

Conclusions:

  • In cells resistant to CD95-induced apoptosis due to Bcl-xL overexpression, Bcl-xL acts independently and downstream of caspase-8.
  • Bcl-xL confers apoptosis resistance by inhibiting events subsequent to caspase-8 activation.

Related Concept Videos